Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in MYGN — Myriad Genetics Inc

CIK 1214717 BOSTON, MA

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,437,205
-$3,285,240 QoQ
Shares Held
2,319,379
+3.9% QoQ
Ownership
2.46%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $15,321,128,020 across 43 Diagnostics & Research names. MYGN ranks #29 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,437,205 2,319,379
2025-12-31 $13,722,445 2,231,292
2025-09-30 $16,087,970 2,225,169
2025-06-30 $11,803,927 2,222,962
2025-03-31 $19,786,894 2,230,766
2024-12-31 $29,378,733 2,142,869
2024-09-30 $58,999,017 2,154,035
2024-06-30 $52,168,654 2,132,815
2024-03-31 $42,989,051 2,016,372
2023-12-31 $35,827,342 1,871,857
2023-09-30 $27,699,219 1,726,884
2023-06-30 $38,591,153 1,664,847
2023-03-31 $37,263,405 1,604,107
2022-12-31 $22,138,980 1,525,774
2022-09-30 $28,062,291 1,470,770
2022-06-30 $26,260,955 1,445,292
2022-03-31 $36,488,516 1,447,957
2021-12-31 $39,442,552 1,429,078
2021-09-30 $44,551,029 1,379,716
2021-06-30 $41,703,933 1,363,765
2021-03-31 $38,478,964 1,263,677
2020-12-31 $22,616,207 1,143,966
2020-09-30 $14,642,276 1,122,874
2020-06-30 $12,992,248 1,145,701
2020-03-31 $15,807,198 1,104,626